Director Shareholding

Clinical Computing PLC
12 November 2004

                            SCHEDULE 11

     NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED 
                        PERSONS


1)  NAME OF COMPANY

    CLINICAL COMPUTING PLC

2)  NAME OF DIRECTOR
    
    JOSEPH G MARLOVITS   

3)  Please state whether notification indicates that it is in respect of
    holding of the shareholder named in 2 above or in respect of a
    non-beneficial interest or in the case of an individual holder
    if it is a holding of that person's spouse or children under the
    age of 18 or in respect of an non-beneficial interest

     NAMED  DIRECTOR

4)  Name of the registered holder(s) and, if more than one holder, the
    number of shares held by each of them. (If notified)



5)  Please state whether notification relates to a person(s) connected
    with the Director named in 2 above and identify the connected person(s)

    

6)  Please state the nature of the transaction. For PEP transactions
    please indicate whether general/single co PEP and if discretionary/non
    discretionary

     

7)  Number of shares/amount of
    stock acquired

     

8)  Percentage of issued Class

    

9)  Number of shares/amount
    of stock disposed

    

10) Percentage of issued Class

  

11) Class of security

    

12) Price per share

    

13) Date of transaction

    
14) Date company informed

    

15) Total holding following this notification

     
16) Total percentage holding of issued class following this notification

     

     IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
                    COMPLETE THE FOLLOWING BOXES

17) Date of grant

    10 NOVEMBER 2004

18) Period during which or date on which exercisable

    10 NOVEMBER 2007
     9 NOVEMBER 2014 

19) Total amount paid (if any) for grant of the option

     NIL

20) Description of shares or debentures involved: class, number.

     ORDINARY 5P

21) Exercise price (if fixed at time of grant) or indication that price
    is to be fixed at time of exercise

      32P

22) Total number of shares or debentures over which options held
    following this notification

    100,000

23) Any additional information



24) Name of contact and telephone number for queries

      
      JOSEPH MARLOVITS  - Tel: [phone]


25) Name and signature of authorised company official responsible for
    making this notification    JOSEPH G MARLOVITS

    Date of Notification     12 NOVEMBER, 2004                              




                       




                      This information is provided by RNS
            The company news service from the London Stock Exchange